| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 72-85, Copyright © 1995 by Endocrine Society
ARTICLES |
W Seol, HS Choi and DD Moore
Department of Molecular Biology, Massachusetts General Hospital, Boston, 02114, USA.
We have used a yeast genetic system to isolate cDNAs encoding proteins that specifically interact with the ligand-binding domain of human retinoid X receptor-alpha (RXR alpha). A number encoded portions of two known RXR heterodimer partners, the retinoic acid receptor (RAR) and the peroxisome proliferator activated receptor. Of four additional RXR- interacting proteins (RIPs) selected for further study two, RIP14 and RIP15, are previously unidentified orphan members of the nuclear receptor superfamily. Two others, RIP110 and RIP13, do not show significant similarities to previously reported proteins. RIP110 interacts with LexA-RXR only in yeast cells grown in the presence of the RXR ligand 9-cis-RA, while the interaction of the four receptor superfamily members and RIP13 is unaffected by the presence or absence of 9-cis-RA. RIP110 and RIP13 also interact in yeast with several other members of the receptor superfamily, but RIP14 and RIP15 interact only with RXR. Analysis of larger cDNA clones demonstrates that there are at least two isoforms of RIP14 that differ in the N-terminal (A and B) and hinge (D) domains. Northern blot analysis indicates that RIP14 is expressed specifically in liver and kidney, while RIP15 is expressed in every tissue tested. Both RIP14 and 15 bind as heterodimers with RXR to the RA response element (RARE) from the promoter of the RAR beta 2 isoform (the beta RARE), and RIP14 and RXR heterodimers also bind the ecdysone response element from the Drosophila heat shock protein 27 promoter. Both heterodimers also bind to several synthetic RAREs and other elements. In cotransfections, neither RIP14 nor RIP15 trans- activates a reporter containing multiple copies of the beta RARE under any of a variety of conditions, suggesting that their activities are dependent on the binding of as yet unidentified specific ligands or on activation by other processes.
This article has been cited by other articles:
 |
|
 |
|
  P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation Physiol Rev, January 1, 2009; 89(1): 147 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Chaudhuri Nuclear Receptors and Female Reproduction: A Tale of 3 Scientists, Jensen, Gustafsson, and O'Malley Reproductive Sciences, February 1, 2008; 15(2): 110 - 120. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Talukdar, S. Bhatnagar, S. Dridi, and F. B. Hillgartner Chenodeoxycholic acid suppresses the activation of acetyl-coenzyme A carboxylase-{alpha} gene transcription by the liver X receptor agonist T0-901317 J. Lipid Res., December 1, 2007; 48(12): 2647 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lee, M. L. Hubbert, T. F. Osborne, K. Woodford, N. Zerangue, and P. A. Edwards Regulation of the Sodium/Sulfate Co-transporter by Farnesoid X Receptor {alpha} J. Biol. Chem., July 27, 2007; 282(30): 21653 - 21661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Hirsch-Reinshagen, J. Y. Chan, A. Wilkinson, T. Tanaka, J. Fan, G. Ou, L. F. Maia, R. R. Singaraja, M. R. Hayden, and C. L. Wellington Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-{beta} peptide levels in vivo J. Lipid Res., April 1, 2007; 48(4): 914 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Moore, S. Kato, W. Xie, D. J. Mangelsdorf, D. R. Schmidt, R. Xiao, and S. A. Kliewer International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor {alpha}, Farnesoid X Receptor beta, Liver X Receptor {alpha}, Liver X Receptor beta, and Vitamin D Receptor Pharmacol. Rev., December 1, 2006; 58(4): 742 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer International Union of Pharmacology. LXIII. Retinoid X Receptors Pharmacol. Rev., December 1, 2006; 58(4): 760 - 772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Caron, B. Cariou, and B. Staels FXR: More than a Bile Acid Receptor? Endocrinology, September 1, 2006; 147(9): 4022 - 4024. [Full Text] [PDF]
|
|
|
|
|
|
H. Lee, Y. Zhang, F. Y. Lee, S. F. Nelson, F. J. Gonzalez, and P. A. Edwards FXR regulates organic solute transporters {alpha} and {alpha} in the adrenal gland, kidney, and intestine J. Lipid Res., January 1, 2006; 47(1): 201 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Claudel, B. Staels, and F. Kuipers The Farnesoid X Receptor: A Molecular Link Between Bile Acid and Lipid and Glucose Metabolism Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2020 - 2030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Y. Lee, H. R. Kast-Woelbern, J. Chang, G. Luo, S. A. Jones, M. C. Fishbein, and P. A. Edwards {alpha}-Crystallin Is a Target Gene of the Farnesoid X-activated Receptor in Human Livers J. Biol. Chem., September 9, 2005; 280(36): 31792 - 31800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Evans The Nuclear Receptor Superfamily: A Rosetta Stone for Physiology Mol. Endocrinol., June 1, 2005; 19(6): 1429 - 1438. [Full Text] [PDF]
|
|
|
|
|
|
K. M. Robertson, G. U. Schuster, K. R. Steffensen, O. Hovatta, S. Meaney, K. Hultenby, L. C. Johansson, K. Svechnikov, O. Soder, and J.-A. Gustafsson The Liver X Receptor-{beta} Is Essential for Maintaining Cholesterol Homeostasis in the Testis Endocrinology, June 1, 2005; 146(6): 2519 - 2530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fiorucci, C. Clerici, E. Antonelli, S. Orlandi, B. Goodwin, B. M. Sadeghpour, G. Sabatino, G. Russo, D. Castellani, T. M. Willson, et al. Protective Effects of 6-Ethyl Chenodeoxycholic Acid, a Farnesoid X Receptor Ligand, in Estrogen-Induced Cholestasis J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 604 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Anisfeld, H. R. Kast-Woelbern, H. Lee, Y. Zhang, F. Y. Lee, and P. A. Edwards Activation of the nuclear receptor FXR induces fibrinogen expression: a new role for bile acid signaling J. Lipid Res., March 1, 2005; 46(3): 458 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Savkur, J. S. Thomas, K. S. Bramlett, Y. Gao, L. F. Michael, and T. P. Burris Ligand-Dependent Coactivation of the Human Bile Acid Receptor FXR by the Peroxisome Proliferator-Activated Receptor {gamma} Coactivator-1{alpha} J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 170 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sirvent, A. J. M. Verhoeven, H. Jansen, V. Kosykh, R. J. Darteil, D. W. Hum, J.-C. Fruchart, and B. Staels Farnesoid X receptor represses hepatic lipase gene expression J. Lipid Res., November 1, 2004; 45(11): 2110 - 2115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Duran-Sandoval, G. Mautino, G. Martin, F. Percevault, O. Barbier, J.-C. Fruchart, F. Kuipers, and B. Staels Glucose Regulates the Expression of the Farnesoid X Receptor in Liver Diabetes, April 1, 2004; 53(4): 890 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, L. W. Castellani, C. J. Sinal, F. J. Gonzalez, and P. A. Edwards Peroxisome proliferator-activated receptor-{gamma} coactivator 1{alpha} (PGC-1{alpha}) regulates triglyceride metabolism by activation of the nuclear receptor FXR Genes & Dev., January 15, 2004; 18(2): 157 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. McMullen, F. H. Andrade, and J. S. Stahl Functional and Genomic Changes in the Mouse Ocular Motor System in Response to Light Deprivation from Birth J. Neurosci., January 7, 2004; 24(1): 161 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Guo, G. Lambert, M. Negishi, J. M. Ward, H. B. Brewer Jr., S. A. Kliewer, F. J. Gonzalez, and C. J. Sinal Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity J. Biol. Chem., November 14, 2003; 278(46): 45062 - 45071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Bramlett, K. A. Houck, K. M. Borchert, M. S. Dowless, P. Kulanthaivel, Y. Zhang, T. P. Beyer, R. Schmidt, J. S. Thomas, L. F. Michael, et al. A Natural Product Ligand of the Oxysterol Receptor, Liver X Receptor J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 291 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ishizuka and M. A. Lazar The N-CoR/Histone Deacetylase 3 Complex Is Required for Repression by Thyroid Hormone Receptor Mol. Cell. Biol., August 1, 2003; 23(15): 5122 - 5131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Holt, G. Luo, A. N. Billin, J. Bisi, Y. Y. McNeill, K. F. Kozarsky, M. Donahee, D. Y. Wang, T. A. Mansfield, S. A. Kliewer, et al. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis Genes & Dev., July 1, 2003; 17(13): 1581 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Inaba, M. Matsuda, M. Shimamura, N. Takei, N. Terasaka, Y. Ando, H. Yasumo, R. Koishi, M. Makishima, and I. Shimomura Angiopoietin-like Protein 3 Mediates Hypertriglyceridemia Induced by the Liver X Receptor J. Biol. Chem., June 6, 2003; 278(24): 21344 - 21351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Giangrande, T. C. Hallstrom, C. Tunyaplin, K. Calame, and J. R. Nevins Identification of E-Box Factor TFE3 as a Functional Partner for the E2F3 Transcription Factor Mol. Cell. Biol., June 1, 2003; 23(11): 3707 - 3720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lambert, M. J. A. Amar, G. Guo, H. B. Brewer Jr., F. J. Gonzalez, and C. J. Sinal The Farnesoid X-receptor Is an Essential Regulator of Cholesterol Homeostasis J. Biol. Chem., January 17, 2003; 278(4): 2563 - 2570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, H. R. Kast-Woelbern, and P. A. Edwards Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional Activation J. Biol. Chem., January 3, 2003; 278(1): 104 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mo, S. J. Fang, W. Chen, and G. C. Blobe Regulation of ALK-1 Signaling by the Nuclear Receptor LXRbeta J. Biol. Chem., December 20, 2002; 277(52): 50788 - 50794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Brendel, K. Schoonjans, O. A. Botrugno, E. Treuter, and J. Auwerx The Small Heterodimer Partner Interacts with the Liver X Receptor {alpha} and Represses Its Transcriptional Activity Mol. Endocrinol., September 1, 2002; 16(9): 2065 - 2076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Yan, Y.-S. Kim, and A. M. Jetten RAP80, a Novel Nuclear Protein That Interacts with the Retinoid-related Testis-associated Receptor J. Biol. Chem., August 23, 2002; 277(35): 32379 - 32388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Y. L. Chiang Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors Endocr. Rev., August 1, 2002; 23(4): 443 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Dussault, M. Lin, K. Hollister, M. Fan, J. Termini, M. A. Sherman, and B. M. Forman A Structural Model of the Constitutive Androstane Receptor Defines Novel Interactions That Mediate Ligand-Independent Activity Mol. Cell. Biol., August 1, 2002; 22(15): 5270 - 5280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cui, T. S. Heard, J. Yu, J.-L. Lo, L. Huang, Y. Li, J. M. Schaeffer, and S. D. Wright The Amino Acid Residues Asparagine 354 and Isoleucine 372 of Human Farnesoid X Receptor Confer the Receptor with High Sensitivity to Chenodeoxycholate J. Biol. Chem., July 12, 2002; 277(29): 25963 - 25969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-W. Seo, S. Sanyal, H.-J. Kim, D. H. Won, J.-Y. An, T. Amano, A. M. Zavacki, H.-B. Kwon, Y.-B. Shi, W.-S. Kim, et al. FOR, a Novel Orphan Nuclear Receptor Related to Farnesoid X Receptor J. Biol. Chem., May 10, 2002; 277(20): 17836 - 17844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Edwards, H. R. Kast, and A. M. Anisfeld BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis J. Lipid Res., January 1, 2002; 43(1): 2 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Kast, C. M. Nguyen, C. J. Sinal, S. A. Jones, B. A. Laffitte, K. Reue, F. J. Gonzalez, T. M. Willson, and P. A. Edwards Farnesoid X-Activated Receptor Induces Apolipoprotein C-II Transcription: a Molecular Mechanism Linking Plasma Triglyceride Levels to Bile Acids Mol. Endocrinol., October 1, 2001; 15(10): 1720 - 1728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Cohen, S. Brzostek, B. Kim, M. Chorev, F. E. Wondisford, and A. N. Hollenberg The Specificity of Interactions between Nuclear Hormone Receptors and Corepressors Is Mediated by Distinct Amino Acid Sequences within the Interacting Domains Mol. Endocrinol., July 1, 2001; 15(7): 1049 - 1061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Yen Physiological and Molecular Basis of Thyroid Hormone Action Physiol Rev, July 1, 2001; 81(3): 1097 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-K. Lee, S.-Y. Jung, Y.-S. Kim, S.-Y. Na, Y. C. Lee, and J. W. Lee Two Distinct Nuclear Receptor-Interaction Domains and CREB-Binding Protein-Dependent Transactivation Function of Activating Signal Cointegrator-2 Mol. Endocrinol., February 1, 2001; 15(2): 241 - 254. [Abstract] [Full Text]
|
|
|
|
|
|
F. D. Urnov and A. P. Wolffe A Necessary Good: Nuclear Hormone Receptors and Their Chromatin Templates Mol. Endocrinol., January 1, 2001; 15(1): 1 - 16. [Full Text]
|
|
|
|
|
|
P. Webb, C. M. Anderson, C. Valentine, P. Nguyen, A. Marimuthu, B. L. West, J. D. Baxter, and P. J. Kushner The Nuclear Receptor Corepressor (N-CoR) Contains Three Isoleucine Motifs (I/LXXII) That Serve as Receptor Interaction Domains (IDs) Mol. Endocrinol., December 1, 2000; 14(12): 1976 - 1985. [Abstract] [Full Text]
|
|
|
|
|
|
C. Song and S. Liao Cholestenoic Acid Is a Naturally Occurring Ligand for Liver X Receptor {alpha} Endocrinology, November 1, 2000; 141(11): 4180 - 4184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Mahajan and H. H. Samuels A New Family of Nuclear Receptor Coregulators That Integrate Nuclear Receptor Signaling through CREB-Binding Protein Mol. Cell. Biol., July 15, 2000; 20(14): 5048 - 5063. [Abstract] [Full Text]
|
|
|
|
|
|
R. N. Cohen, A. Putney, F. E. Wondisford, and A. N. Hollenberg The Nuclear Corepressors Recognize Distinct Nuclear Receptor Complexes Mol. Endocrinol., June 1, 2000; 14(6): 900 - 914. [Abstract] [Full Text]
|
|
|
|
|
|
A. Venkateswaran, J. J. Repa, J.-M. A. Lobaccaro, A. Bronson, D. J. Mangelsdorf, and P. A. Edwards Human White/Murine ABC8 mRNA Levels Are Highly Induced in Lipid-loaded Macrophages. A TRANSCRIPTIONAL ROLE FOR SPECIFIC OXYSTEROLS J. Biol. Chem., May 5, 2000; 275(19): 14700 - 14707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. L. Chiang, R. Kimmel, C. Weinberger, and D. Stroup Farnesoid X Receptor Responds to Bile Acids and Represses Cholesterol 7alpha -Hydroxylase Gene (CYP7A1) Transcription J. Biol. Chem., April 6, 2000; 275(15): 10918 - 10924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Laffitte, H. R. Kast, C. M. Nguyen, A. M. Zavacki, D. D. Moore, and P. A. Edwards Identification of the DNA Binding Specificity and Potential Target Genes for the Farnesoid X-activated Receptor J. Biol. Chem., March 31, 2000; 275(14): 10638 - 10647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Giguère Orphan Nuclear Receptors: From Gene to Function Endocr. Rev., October 1, 1999; 20(5): 689 - 725. [Abstract] [Full Text]
|
|
|
|
|
|
J. Zhang, X. Hu, and M. A. Lazar A Novel Role for Helix 12 of Retinoid X Receptor in Regulating Repression Mol. Cell. Biol., September 1, 1999; 19(9): 6448 - 6457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Dowell, J. E. Ishmael, D. Avram, V. J. Peterson, D. J. Nevrivy, and M. Leid Identification of Nuclear Receptor Corepressor as a Peroxisome Proliferator-activated Receptor alpha Interacting Protein J. Biol. Chem., May 28, 1999; 274(22): 15901 - 15907. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Makishima, A. Y. Okamoto, J. J. Repa, H. Tu, R. M. Learned, A. Luk, M. V. Hull, K. D. Lustig, D. J. Mangelsdorf, and B. Shan Identification of a Nuclear Receptor for Bile Acids Science, May 21, 1999; 284(5418): 1362 - 1365. [Abstract] [Full Text]
|
|
|
|
|
|
D. J. Parks, S. G. Blanchard, R. K. Bledsoe, G. Chandra, T. G. Consler, S. A. Kliewer, J. B. Stimmel, T. M. Willson, A. M. Zavacki, D. D. Moore, et al. Bile Acids: Natural Ligands for an Orphan Nuclear Receptor Science, May 21, 1999; 284(5418): 1365 - 1368. [Abstract] [Full Text]
|
|
|
|
|
|
S. A. Kliewer, J. M. Lehmann, and T. M. Willson Orphan Nuclear Receptors: Shifting Endocrinology into Reverse Science, April 30, 1999; 284(5415): 757 - 760. [Abstract] [Full Text]
|
|
|
|
|
|
D. Feltkamp, F. F. Wiebel, S. Alberti, and J.-A. Gustafsson Identification of a Novel DNA Binding Site for Nuclear Orphan Receptor OR1 J. Biol. Chem., April 9, 1999; 274(15): 10421 - 10429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.-J. Park, D. J. Schroen, M. Yang, H. Li, L. Li, and J. D. Chen SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor PNAS, March 30, 1999; 96(7): 3519 - 3524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-W. Wong and M. L. Privalsky Transcriptional Silencing Is Defined by Isoform- and Heterodimer-Specific Interactions between Nuclear Hormone Receptors and Corepressors Mol. Cell. Biol., October 1, 1998; 18(10): 5724 - 5733. [Abstract] [Full Text]
|
|
|
|
|
|
R. N. Cohen, F. E. Wondisford, and A. N. Hollenberg Two Separate NCoR (Nuclear Receptor Corepressor) Interaction Domains Mediate Corepressor Action on Thyroid Hormone Response Elements Mol. Endocrinol., October 1, 1998; 12(10): 1567 - 1581. [Abstract] [Full Text]
|
|
|
|
|
|
M. Kullmann, J. Schneikert, J. Moll, S. Heck, M. Zeiner, U. Gehring, and A. C. B. Cato RAP46 Is a Negative Regulator of Glucocorticoid Receptor Action and Hormone-induced Apoptosis J. Biol. Chem., June 5, 1998; 273(23): 14620 - 14625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li and J. D. Chen The Receptor-associated Coactivator 3 Activates Transcription through CREB-binding Protein Recruitment and Autoregulation J. Biol. Chem., March 6, 1998; 273(10): 5948 - 5954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Na, H.-J. Kim, S.-K. Lee, H.-S. Choi, D.-S. Na, M.-O. Lee, M. Chung, D. D. Moore, and J. W. Lee Ikappa Bbeta Interacts with the Retinoid X Receptor and Inhibits Retinoid-dependent Transactivation in Lipopolysaccharide-treated Cells J. Biol. Chem., February 6, 1998; 273(6): 3212 - 3215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Zavacki, J. M. Lehmann, W. Seol, T. M. Willson, S. A. Kliewer, and D. D. Moore Activation of the orphan receptor RIP14 by retinoids PNAS, July 22, 1997; 94(15): 7909 - 7914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
